RxDoctor Payments DataLook up a doctor →

TEZSPIRE: payments to doctors

Payments that named TEZSPIRE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$23.3M
Providers
21,547
Transactions
205,244
Average per transaction
$113

The per-transaction average — $113 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 21,547 providers the average total is $1,080, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
AstraZeneca$19,315,55583.0%
Amgen$3,866,84316.6%
Astrazeneca UK Limited$62,6510.3%
Astrazeneca AB$24,3470.1%
← All drugs & devices